DNB Asset Management AS trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 19.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,958 shares of the financial services provider’s stock after selling 18,380 shares during the period. DNB Asset Management AS’s holdings in CME Group were worth $20,523,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Choreo LLC boosted its stake in CME Group by 3.5% in the third quarter. Choreo LLC now owns 11,542 shares of the financial services provider’s stock valued at $3,118,000 after acquiring an additional 387 shares during the last quarter. West Family Investments Inc. raised its holdings in shares of CME Group by 1.2% in the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after purchasing an additional 37 shares during the period. Mesirow Financial Investment Management Inc. raised its holdings in shares of CME Group by 14.4% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 19,481 shares of the financial services provider’s stock worth $5,264,000 after purchasing an additional 2,448 shares during the period. Westpac Banking Corp lifted its stake in CME Group by 28.2% in the third quarter. Westpac Banking Corp now owns 52,514 shares of the financial services provider’s stock valued at $14,189,000 after purchasing an additional 11,553 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in CME Group by 3.6% during the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,772,731 shares of the financial services provider’s stock valued at $749,164,000 after purchasing an additional 96,583 shares during the period. Institutional investors own 87.75% of the company’s stock.
Insiders Place Their Bets
In other CME Group news, Director Bryan T. Durkin sold 4,200 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the completion of the transaction, the director owned 43,007 shares of the company’s stock, valued at approximately $13,317,117.55. This trade represents a 8.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Dennis Suskind sold 748 shares of CME Group stock in a transaction on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the transaction, the director owned 2,699 shares of the company’s stock, valued at $809,700. The trade was a 21.70% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 30,248 shares of company stock valued at $8,355,450 over the last quarter. 0.30% of the stock is owned by company insiders.
Key Stories Impacting CME Group
- Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
- Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
- Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
- Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
- Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
- Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates
CME Group Stock Up 1.0%
Shares of CME opened at $319.50 on Friday. CME Group Inc. has a 1 year low of $248.53 and a 1 year high of $322.57. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02. The stock has a 50 day simple moving average of $287.63 and a two-hundred day simple moving average of $275.97. The firm has a market cap of $115.21 billion, a P/E ratio of 28.63, a P/E/G ratio of 3.70 and a beta of 0.27.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the business posted $2.52 earnings per share. The company’s revenue was up 8.1% on a year-over-year basis. On average, analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be issued a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.6%. This is an increase from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date is Tuesday, March 10th. CME Group’s dividend payout ratio (DPR) is presently 44.80%.
Analyst Ratings Changes
Several equities research analysts recently weighed in on CME shares. Rothschild & Co Redburn lifted their price objective on CME Group from $300.00 to $333.00 and gave the stock a “neutral” rating in a report on Thursday, February 12th. Barclays lifted their target price on shares of CME Group from $304.00 to $312.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 5th. Morgan Stanley upped their price target on shares of CME Group from $319.00 to $340.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. TD Cowen raised their price objective on shares of CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Finally, Jefferies Financial Group dropped their price objective on CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $299.53.
Read Our Latest Research Report on CME Group
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- Unlocked: Elon Musk’s Next Big IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
- Read this or regret it forever
- Silver paying 20% dividend. Plus 68% share gains
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
